PD3-2-7: Implications of tumour cavitation on response assessment in trials of Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors in combination with platinum-based chemotherapy for advanced non-small cell lung cancer (NSCLC): An analysis of trials conducted by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Conferences uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • Laurie, Scott A
  • Crabb, Simon
  • Arnold, Andrew
  • Goss, Glen
  • Shepherd, Frances A
  • Seymour, Lesley

publication date

  • August 2007